FDA Panel Backs New COVID Vaccines
The FDA's vaccine advisors voted 8 to 0, with one abstention, in favor of a monovalent XFG vaccine aimed at the dominant strain. The vote occurred during a panel meeting. These vaccines are expected to offer enhanced protection against current and future variants. The vaccines are designed to target emerging variants.
Topics
Developing
- 880d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 880d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 880d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 880d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
Mastodon
“FDA Panel Backs New COVID Vaccines Aimed at Dominant StrainThe FDA’s vaccine advisors voted 8 to 0, with one abstention, in favor of a monovalent XFG vaccine…”
106.1 NxtRadio
“Точно со Turn the On the catch When we're Doing the so I will Wanna feel Ha”
NPR News
“An FDA panel has recommended backing new COVID-19 vaccines.”
90.7 WMFE-FM
“Texton how And having str Having shown Yeah Um provid Yeah Reader Did it come back Did it open up Opportunity for And he translated”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade